LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 35.77 | 21.74 | 11 | 2602 | 0.0042 | -0.0940 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 35.77 | 21.74 | 2741 | 2602 | 1.0531 | 1.0150 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.74 | 21.74 | 269 | 2828 | 0.0951 | 0.4307 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.74 | 21.74 | 2761 | 2828 | 0.9762 | 0.9931 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.74 | 21.74 | 5 | 2828 | 0.0018 | -0.1888 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.74 | 21.74 | 2980 | 2828 | 1.0536 | 1.0149 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.71 | 21.74 | 294 | 3084 | 0.0953 | 0.4396 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.71 | 21.74 | 2890 | 3084 | 0.9371 | 0.9819 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.71 | 21.74 | 7 | 3084 | 0.0023 | -0.1466 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 39.71 | 21.74 | 3198 | 3084 | 1.0369 | 1.0102 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.68 | 21.74 | 368 | 3418 | 0.1076 | 0.4736 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.68 | 21.74 | 3208 | 3418 | 0.9383 | 0.9826 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.68 | 21.74 | 9 | 3418 | 0.0026 | -0.1138 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.68 | 21.74 | 3459 | 3418 | 1.0118 | 1.0032 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.65 | 21.74 | 464 | 3754 | 0.1236 | 0.5096 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.65 | 21.74 | 3526 | 3754 | 0.9392 | 0.9832 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.65 | 21.74 | 18 | 3754 | 0.0048 | -0.0251 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.65 | 21.74 | 3888 | 3754 | 1.0356 | 1.0094 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.62 | 21.74 | 490 | 4150 | 0.1181 | 0.5086 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.62 | 21.74 | 3800 | 4150 | 0.9155 | 0.9768 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.62 | 21.74 | 7 | 4150 | 0.0017 | -0.1389 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.62 | 21.74 | 4257 | 4150 | 1.0256 | 1.0067 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.59 | 21.74 | 579 | 4492 | 0.1289 | 0.5323 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.59 | 21.74 | 4145 | 4492 | 0.9227 | 0.9792 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.59 | 21.74 | 2 | 4492 | 0.0004 | -0.2667 | MN20160310_N01 | G16 |